QuiVad
My list

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on September 22, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.19%newSeptember 22, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

439 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 19, 2021Consonance Capital Management LP0.84%
August 19, 2021Worldquant LLC0.57%
August 18, 2021Citadel Advisors LLC1.11%
August 18, 2021Consonance Capital Management LP1.07%
August 17, 2021Arrowstreet Capital Limited Partnership1.24%
August 17, 2021Consonance Capital Management LP1.17%
August 17, 2021Capital Fund Management SA0.60%
August 16, 2021Consonance Capital Management LP1.24%
August 12, 2021Citadel Advisors LLC1.08%
August 11, 2021Citadel Advisors LLC1.15%
August 11, 2021PDT Partners LLC0.81%
August 10, 2021Arrowstreet Capital Limited Partnership1.11%
August 10, 2021Citadel Advisors LLC1.04%
August 9, 2021PDT Partners LLC0.73%
August 6, 2021Marshall Wace LLP0.99%
August 4, 2021Mangrove Partners0.84%
August 4, 2021PDT Partners LLC0.60%
August 2, 2021Adage Capital Management LP1.32%
July 30, 2021Adage Capital Management LP1.27%
July 30, 2021Citadel Advisors LLC0.91%
July 30, 2021Capital Fund Management SA0.51%
July 30, 2021PDT Partners LLC0.50%
July 29, 2021Adage Capital Management LP1.15%
July 29, 2021Citadel Advisors LLC1.03%
July 29, 2021Arrowstreet Capital Limited Partnership1.01%
July 29, 2021Capital Fund Management SA0.00%
July 29, 2021Hrteu Limited0.00%
July 28, 2021Marshall Wace LLP1.06%
July 28, 2021Citadel Advisors LLC0.97%
July 28, 2021Adage Capital Management LP0.95%
July 28, 2021Capital Fund Management SA0.54%
July 27, 2021Citadel Advisors LLC1.10%
July 23, 2021Citadel Advisors LLC1.01%
July 23, 2021Worldquant LLC0.00%
July 22, 2021Marshall Wace LLP1.13%
July 22, 2021Citadel Advisors LLC0.99%
July 22, 2021Worldquant LLC0.53%
July 21, 2021Marshall Wace LLP1.07%
July 21, 2021Citadel Advisors LLC1.00%
July 21, 2021Arrowstreet Capital Limited Partnership0.90%
July 21, 2021Worldquant LLC0.68%
July 21, 2021HRTEU Limited0.54%
July 21, 2021Capital Fund Management SA0.00%
July 20, 2021Consonance Capital Management LP1.41%July 20, 2021
July 20, 2021Citadel Advisors LLC0.96%
July 20, 2021Marshall Wace LLP0.94%
July 20, 2021Worldquant LLC0.75%
July 20, 2021Capital Fund Management SA0.50%
July 19, 2021Consonance Capital Management LP1.21%
July 19, 2021Marshall Wace LLP0.83%

Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=7